Rapamycin, an inhibitor of mTOR signaling, has been reported to alleviate the symptoms of seizures, anxiety, and depression in PTZ-kindled rats by inhibiting NLRP3 inflammasomes and ROS production [174]. Here, NLRP3 is linked to depressive disorder.